Neuralink Pre-IPO Shares

Implantable brain–computer interfaces.

Limen Markets Private offers accredited investors access to Neuralink secondary equity under Reg D 506(c) — typically structured as single-series SPVs with a $25,000 minimum, transparent fee terms, and settlement measured in days. Live indicative pricing, implied valuation, current availability, and offering details load below.

For a deeper look at supply, valuation benchmarks, and deal structure, read our Neuralink secondary market analysis.